Asia Pacific Over-The-Counter (OTC) Drugs Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Historical Data Period | 2019 - 2022 |
| CAGR | 8.30 % |
Major Players_Drugs_Market_1.webp "Asia-Pacific Over-the-counter (OTC) Drugs Market Major Players")
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Asia Pacific Over-The-Counter (OTC) Drugs Market Analysis
The growth propelling factors of the Asia-Pacific over-the-counter (OTC) drugs market are product innovations, high penetration in emerging countries, like India and China, and the inclination of pharmaceutical companies toward OTC drugs over prescription drugs. This can be attributed to the rapidly growing population and an increase in the disposable income of the population, which may add critical mass to the population available to access OTC medication. Along with new channels of accessibility in the emerging markets in retail outlets, supermarkets are contributing to the growth of the OTC medication market in Asia-Pacific. However, the lack of awareness among the population and incorrect self-diagnosis are expected to hamper the market growth.
Asia Pacific Over-The-Counter (OTC) Drugs Market Trends
This section covers the major market trends shaping the APAC Over-the-Counter Drugs Market according to our research experts:
Cough, Cold, and Flu Products Segment May Hold Significant Market Share over the Forecast Period
The OTC market has been witnessing strong growth resulting from the rising demand from the consumers to self-medicate. In countries with high population, such as China and India, the patients mostly rely on their neighborhood chemist to prescribe the appropriate medicines for illnesses, such as cough, cold, nasal congestion, or fever. In India, the frequency of certain ailments, like common colds and headaches, is significantly high and inconsistent across states. At the same time, consumers are becoming more prone to seeking over-the-counter (OTC) remedies and medicines rather than checking in with their physicians. In India, consumers are found to be dependent on OTC for cough, cold, or flu medicines, as these drugs are believed to offer instant relief. Owing to their easy procurement, the sales of OTC drugs for cough, cold, and flu have increased. Furthermore, many countries in South Asia-Pacific and Japan have a large number of the elderly population who are more prone to diseases. Thus, this factor is also likely to drive the OTC drugs market in the future.
_Drugs_Market_2.webp "Asia-Pacific Over-the-counter (OTC) Drugs Market Trends")
Asia Pacific Over-The-Counter (OTC) Drugs Industry Overview
The over-the-counter drugs market is highly competitive and consists of several major players. In terms of market share, few of the major players currently dominate the market. However, with technological advancements and product innovation, mid-size to smaller companies are increasing their market presence by introducing new products with fewer prices. For instance, in April 2018, Procter & Gamble Company acquired the Consumer Health business of Merck KGaA. Companies, like Johnson & Johnson, GlaxoSmithKline PLC, and Sanofi, hold significant market shares in the over-the-counter drugs market.
Asia Pacific Over-The-Counter (OTC) Drugs Market Leaders
-
GlaxoSmithKline PLC
-
Johnson & Johnson
-
Boehringer Ingelheim International GmbH
-
Procter & Gamble
-
Sanofi SA
*Disclaimer: Major Players sorted in no particular order
_Drugs_Market.webp "Asia-Pacific Over-the-counter (OTC) Drugs Market Concentration")
Asia Pacific Over-The-Counter (OTC) Drugs Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Deliverables
- 1.2 Study Assumptions
- 1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Product Innovation
- 4.2.2 High Penetration in Emerging Markets
- 4.2.3 Inclination of Pharmaceutical Companies to Switch from Rx to OTC Drugs
-
4.3 Market Restraints
- 4.3.1 Lack of Awareness Among the Population
- 4.3.2 Incorrect Self-diagnosis
-
4.4 Porter's Five Forces Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
-
5.1 By Product Type
- 5.1.1 Cough, Cold, and Flu Products
- 5.1.2 Analgesics
- 5.1.3 Dermatology Products
- 5.1.4 Gastrointestinal Products
- 5.1.5 Vitamins, Mineral, and Supplements (VMS)
- 5.1.6 Weight-loss/Dietary Products
- 5.1.7 Ophthalmic Products
- 5.1.8 Sleeping Aids
- 5.1.9 Other Product Types
-
5.2 By Distribution Channel
- 5.2.1 Hospital Pharmacies
- 5.2.2 Retail Pharmacies
- 5.2.3 Online Pharmacy
- 5.2.4 Other Distribution Channels
-
5.3 By Geography
- 5.3.1 Asia-Pacific
- 5.3.1.1 China
- 5.3.1.2 Japan
- 5.3.1.3 India
- 5.3.1.4 Australia
- 5.3.1.5 South Korea
- 5.3.1.6 Rest of Asia-Pacific
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Johnson & Johnson
- 6.1.2 Sanofi SA
- 6.1.3 GlaxoSmithKline PLC
- 6.1.4 Boehringer Ingelheim International GmbH
- 6.1.5 Abbott Laboratories
- 6.1.6 Dabur India Limited
- 6.1.7 Procter & Gamble
- 6.1.8 Reckitt Benckiser Group PLC
- 6.1.9 Takeda Pharmaceutical Company Limited
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Asia Pacific Over-The-Counter (OTC) Drugs Industry Segmentation
As per the scope of this report, over-the-counter drugs are referred to as non-prescription drugs. These medicines can be bought by an individual without the doctor's prescription and are safe for consumption without the doctor's consent.
| By Product Type | Cough, Cold, and Flu Products | |
| Analgesics | ||
| Dermatology Products | ||
| Gastrointestinal Products | ||
| Vitamins, Mineral, and Supplements (VMS) | ||
| Weight-loss/Dietary Products | ||
| Ophthalmic Products | ||
| Sleeping Aids | ||
| Other Product Types | ||
| By Distribution Channel | Hospital Pharmacies | |
| Retail Pharmacies | ||
| Online Pharmacy | ||
| Other Distribution Channels | ||
| By Geography | Asia-Pacific | China |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| Rest of Asia-Pacific |
Asia Pacific Over-The-Counter (OTC) Drugs Market Research FAQs
What is the current Asia-Pacific Over-the-counter (OTC) Drugs Market size?
The Asia-Pacific Over-the-counter (OTC) Drugs Market is projected to register a CAGR of 8.30% during the forecast period (2024-2029)
Who are the key players in Asia-Pacific Over-the-counter (OTC) Drugs Market?
GlaxoSmithKline PLC, Johnson & Johnson, Boehringer Ingelheim International GmbH, Procter & Gamble and Sanofi SA are the major companies operating in the Asia-Pacific Over-the-counter (OTC) Drugs Market.
What years does this Asia-Pacific Over-the-counter (OTC) Drugs Market cover?
The report covers the Asia-Pacific Over-the-counter (OTC) Drugs Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Asia-Pacific Over-the-counter (OTC) Drugs Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Asia Pacific OTC Drugs Industry Report
Statistics for the 2024 Asia Pacific OTC Drugs market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Asia Pacific OTC Drugs analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
